Opening Address: Why MedTech World Exists | Dr. Dylan Attard | MedTech World North America 2026
Why It Matters
The gathering accelerates collaboration that shortens time‑to‑market for medical technologies, boosting patient outcomes and delivering stronger returns for investors.
Key Takeaways
- •Clinical gaps drive MedTech World’s mission to connect innovators.
- •Event unites founders, investors, clinicians to accelerate product adoption.
- •Originated in Malta, now expands globally to health hubs.
- •West Palm Beach chosen for its dense innovation ecosystem.
- •Attard thanks team, sponsors; urges attendees to forge partnerships.
Summary
Dr. Dylan Attard, CEO and co‑founder of MedTech World, opened the North America 2026 conference in West Palm Beach, welcoming the Maltese ambassador, attendees, and online participants. He framed the gathering as a solution to the persistent disconnect between clinicians, innovators, and capital.
Attard explained that his experience as a surgeon exposed “friction of tools that almost work” and highlighted how many promising technologies never reach patients because founders, investors, and clinical teams rarely meet. MedTech World’s model—bringing the right people together in one room—has repeatedly turned those gaps into deals, first on Malta’s small island and now across the Middle East, Asia, and the United States.
He quoted, “When you put the right people in the same room, things move,” and thanked his family, core team members, and sponsors for enabling the five‑year journey. The address underscored that the event is not merely a discussion platform but a catalyst for concrete partnerships.
For the industry, the conference promises accelerated commercialization of breakthrough devices, faster capital deployment, and tighter clinician feedback loops, ultimately shaping the next generation of health‑care delivery in a market hungry for innovation.
Comments
Want to join the conversation?
Loading comments...